Page last updated: 2024-08-21

thiazoles and Affective Disorders

thiazoles has been researched along with Affective Disorders in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's6 (66.67)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, Y; Mansur, RB; McIntyre, RS1
Dietmaier, O; Gansmüller, R; Gründer, G; Hiemke, C; Leiblein, T; Vogel, F; Wassmuth, H1
Jing, Y; Kim, E; Pikalov, A; Tran, QV; You, M1
Cazzaniga, G; Homberg, JR; Hulsken, S; Luoni, A; Racagni, G; Riva, MA1
Black, KJ; Hershey, T; Koller, JM; Mintun, MA; Perlmutter, JS; Price, JL; Videen, TO1
Teich, J1
Baldessarini, RJ; Berry, JM; Centorrino, F; Fogarty, KV; Kidwell, JE; MacLean, E; Salvatore, P1
Daniel, DG; Harvey, PD; Kilts, CD; Lieberman, JA; Nemeroff, CB; Newcomer, JW; Schatzberg, AF; Weiden, PJ1
Horisawa, T; Ishibashi, T; Ishida-Tokuda, K; Kawabe, A; Matsumoto, K; Nakamura, M; Ohno, Y; Sakamoto, H; Tagashira, R; Yabuuti, K1

Reviews

2 review(s) available for thiazoles and Affective Disorders

ArticleYear
A pragmatic approach to the diagnosis and treatment of mixed features in adults with mood disorders.
    CNS spectrums, 2016, Volume: 21, Issue:S1

    Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Cognitive Behavioral Therapy; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Humans; Lithium Compounds; Mood Disorders; Piperazines; Thiazoles

2016
Potential role of 5-HT2 and D2 receptor interaction in the atypical antipsychotic action of the novel succimide derivative, perospirone.
    Polish journal of pharmacology, 1997, Volume: 49, Issue:4

    Topics: Animals; Antipsychotic Agents; Corpus Striatum; Disease Models, Animal; Dopamine Antagonists; Gene Expression Regulation; Indoles; Isoindoles; Mood Disorders; Rats; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Antagonists; Thiazoles

1997

Other Studies

7 other study(ies) available for thiazoles and Affective Disorders

ArticleYear
The use of ziprasidone in clinical practice: analysis of pharmacokinetic and pharmacodynamic aspects from data of a drug monitoring survey.
    European psychiatry : the journal of the Association of European Psychiatrists, 2009, Volume: 24, Issue:3

    Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Male; Mood Disorders; Piperazines; Psychotic Disorders; Retrospective Studies; Severity of Illness Index; Thiazoles; Treatment Outcome

2009
Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    Journal of medical economics, 2009, Volume: 12, Issue:2

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Costs and Cost Analysis; Dibenzothiazepines; Drug Therapy, Combination; Female; Health Care Costs; Humans; Male; Middle Aged; Mood Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Thiazoles; Treatment Outcome; Young Adult

2009
Behavioural and neuroplastic properties of chronic lurasidone treatment in serotonin transporter knockout rats.
    The international journal of neuropsychopharmacology, 2013, Volume: 16, Issue:6

    Topics: Analysis of Variance; Animals; Antidepressive Agents; Antigens, Differentiation; Brain-Derived Neurotrophic Factor; Conditioning, Psychological; Disease Models, Animal; Extinction, Psychological; Fear; Gene Expression Regulation; Isoindoles; Lurasidone Hydrochloride; Mood Disorders; Neuronal Plasticity; Prefrontal Cortex; Protein Transport; Rats; Rats, Transgenic; Rats, Wistar; Receptors, GABA; Receptors, Glucocorticoid; RNA, Messenger; Serotonin Plasma Membrane Transport Proteins; Thiazoles; Vesicular Inhibitory Amino Acid Transport Proteins

2013
A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist.
    Proceedings of the National Academy of Sciences of the United States of America, 2002, Dec-24, Volume: 99, Issue:26

    Topics: Animals; Benzothiazoles; Cerebrovascular Circulation; Dopamine; Dopamine Agonists; Limbic System; Mental Disorders; Mood Disorders; Papio; Pramipexole; Prefrontal Cortex; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles; Tomography, Emission-Computed

2002
Side effects of ziprasidone.
    The American journal of psychiatry, 2003, Volume: 160, Issue:7

    Topics: Antipsychotic Agents; Female; Humans; Hypokalemia; Long QT Syndrome; Magnesium; Middle Aged; Mood Disorders; Piperazines; Thiazoles; Water-Electrolyte Imbalance

2003
Ziprasidone: first year experience in a hospital setting.
    Journal of psychiatric practice, 2004, Volume: 10, Issue:6

    Topics: Adult; Antipsychotic Agents; Depressive Disorder; Electrocardiography; Female; Hospitalization; Humans; Inpatients; Length of Stay; Long QT Syndrome; Male; Middle Aged; Mood Disorders; Piperazines; Retrospective Studies; Schizophrenia; Thiazoles; Treatment Outcome

2004
From clinical research to clinical practice: a 4-year review of ziprasidone.
    CNS spectrums, 2005, Volume: 10, Issue:11 Suppl 1

    Topics: Antipsychotic Agents; Controlled Clinical Trials as Topic; Dopamine Antagonists; Humans; Mood Disorders; Piperazines; Psychotic Disorders; Schizophrenia; Serotonin Antagonists; Thiazoles; Treatment Outcome

2005